Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
JAMA Cardiol. 2022 Jan 1;7(1):65-74. doi: 10.1001/jamacardio.2021.4127.
Preterm delivery has been associated with future cardiometabolic disorders in women. However, the long-term risks of chronic hypertension associated with preterm delivery and whether such risks are attributable to familial confounding are unclear. Such knowledge is needed to improve long-term risk assessment, clinical monitoring, and cardiovascular prevention strategies in women.
To examine the long-term risks of chronic hypertension associated with preterm delivery in a large population-based cohort of women.
DESIGN, SETTING, AND PARTICIPANTS: This national cohort study assessed all 2 195 989 women in Sweden with a singleton delivery from January 1, 1973, to December 31, 2015. Data analyses were conducted from March 8, 2021, to August 20, 2021.
Pregnancy duration identified from nationwide birth records.
New-onset chronic hypertension identified from primary care, specialty outpatient, and inpatient diagnoses using administrative data. Cox proportional hazards regression was used to compute hazard ratios (HRs) while adjusting for preeclampsia, other hypertensive disorders of pregnancy, and other maternal factors. Cosibling analyses were assessed for potential confounding by shared familial (genetic and/or environmental) factors.
In 46.1 million person-years of follow-up, 351 189 of 2 195 989 women (16.0%) were diagnosed with hypertension (mean [SD] age, 55.4 [9.9] years). Within 10 years after delivery, the adjusted HR for hypertension associated with preterm delivery (gestational age <37 weeks) was 1.67 (95% CI, 1.61-1.74) and when further stratified was 2.23 (95% CI, 1.98-2.52) for extremely preterm (22-27 weeks of gestation), 1.85 (95% CI, 1.74-1.97) for moderately preterm (28-33 weeks of gestation), 1.55 (95% CI, 1.48-1.63) for late preterm (34-36 weeks of gestation), and 1.26 (95% CI, 1.22-1.30) for early-term (37-38 weeks of gestation) compared with full-term (39-41 weeks of gestation) delivery. These risks decreased but remained significantly elevated at 10 to 19 years (preterm vs full-term delivery: adjusted HR, 1.40; 95% CI, 1.36-1.44), 20 to 29 years (preterm vs full-term delivery: adjusted HR, 1.20; 95% CI, 1.18-1.23), and 30 to 43 years (preterm vs full-term delivery: adjusted HR, 95% CI, 1.12; 1.10-1.14) after delivery. These findings were not explained by shared determinants of preterm delivery and hypertension within families.
In this large national cohort study, preterm delivery was associated with significantly higher future risks of chronic hypertension. These associations remained elevated at least 40 years later and were largely independent of other maternal and shared familial factors. Preterm delivery should be recognized as a lifelong risk factor for hypertension in women.
早产与女性未来的心血管代谢疾病有关。然而,与早产相关的慢性高血压的长期风险以及这些风险是否归因于家族性混杂因素尚不清楚。这些知识对于改善女性的长期风险评估、临床监测和心血管预防策略是必要的。
在一个大型基于人群的瑞典女性队列中,评估与早产相关的慢性高血压的长期风险。
设计、地点和参与者:这项全国性队列研究评估了 1973 年 1 月 1 日至 2015 年 12 月 31 日期间瑞典所有 2195989 名单胎分娩的女性。数据分析于 2021 年 3 月 8 日至 8 月 20 日进行。
从全国性出生记录中确定妊娠持续时间。
使用行政数据从初级保健、专科门诊和住院诊断中确定新诊断的慢性高血压。使用 Cox 比例风险回归在调整子痫前期、其他妊娠高血压疾病和其他产妇因素后计算危险比(HR)。同胞分析用于评估潜在的家族性(遗传和/或环境)因素混杂。
在 4610 万个人随访年中,2195989 名女性中有 351189 名(16.0%)被诊断为高血压(平均[SD]年龄为 55.4[9.9]岁)。在分娩后 10 年内,与足月分娩(妊娠 37 周)相比,与早产(<37 周)相关的高血压的调整 HR 为 1.67(95%CI,1.61-1.74),进一步分层时为 2.23(95%CI,1.98-2.52),对于极早产(22-27 周妊娠),1.85(95%CI,1.74-1.97)对于中度早产(28-33 周妊娠),1.55(95%CI,1.48-1.63)对于晚期早产(34-36 周妊娠),1.26(95%CI,1.22-1.30)对于早期早产(37-38 周妊娠),与足月分娩(39-41 周妊娠)相比。这些风险在分娩后 10 至 19 年(早产与足月分娩:调整 HR,1.40;95%CI,1.36-1.44)、20 至 29 年(早产与足月分娩:调整 HR,1.20;95%CI,1.18-1.23)和 30 至 43 年(早产与足月分娩:调整 HR,1.12;95%CI,1.10-1.14)时有所下降,但仍显著升高。这些发现不能用家庭内早产和高血压的共同决定因素来解释。
在这项大型全国性队列研究中,早产与女性未来患慢性高血压的风险显著增加有关。这些关联至少在 40 年后仍保持升高,并且在很大程度上独立于其他产妇和共同的家族因素。早产应被视为女性高血压的终身危险因素。